Pfizer (BNT162) and Moderna (mRNA-1273) both have announced the effectiveness of their corona vaccines.
The two Covid-19 vaccine development companies claim that the Covid-19 vaccine candidates they created showed very positive results. Pfizer calls their vaccine 90 percent effective, while Moderna claims 94.5 percent effective.
These two announcements made good news which strengthened positive sentiment amid the corona pandemic. a vaccine to prevent Covid-19 due to infection with the SARS-CoV-2 corona virus is starting to see a bright spot.
Difference between the two Vaccines
Launching NDTV, Pfizer, in collaboration with BioNTech, claims that the effectiveness of the vaccine reaches 90 percent. Meanwhile, Moderna, in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID) and BARDA. The effectiveness of the vaccine reached 94.5 percent.
United States health authorities released guidelines that say each injection must be at least 50 percent effective.
Pfizer Vaccine must be in an ultra-cold temperature of minus 70 degrees Celsius for several days before use. Meanwhile, the Moderna vaccine must be stable at refrigerator temperatures ranging from 2-7 degrees Celsius for 30 days, much longer than the previous estimate of seven days.
The Moderna vaccine can be in the freezer for a longer period of time and does not require the necessary special facilities such as the Pfizer vaccine.
Moderna Vaccine is very expensive. A single dose of Moderna vaccine costs around $38, much higher than the Pfizer vaccine, which is $20.
Although expensive, one dose of Moderna’s mRNA vaccine reaches 100 micrograms. Meanwhile, Pfizer is only 30 micrograms.
Number of vaccinations
Launching Barrons, vaccinations using the Pfizer and Moderna vaccines must be twice. In a clinical trial, a second vaccine dose of Pfizer vaccine was given after 21 days of the patient receiving the first dose of vaccine.
Meanwhile, the second dose of Moderna vaccine was given after 14 days when the patient received the first vaccine dose.
Pfizer and BioNTech globally expects to produce up to 50 million doses of vaccine in 2020 and up to 1.3 billion doses in 2021.
While the Moderna claims will produce 500 million to 1 billion doses per year, starting in 2021.